4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-134684
Chief Operating Officer sold 10,000 shares at an average $28.19 ($281,857)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gault Cheryl · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-30 | Sale : show line 1 in the form 10b5-1 | −7,161 | $28.04 | $200,795 | 162,753 | D |
| 2026-03-30 | Sale : show line 2 in the form 10b5-1 | −2,839 | $28.55 | $81,062 | 159,914 | D |
| Open-market sales · 10,000 sh · avg $28.19 · $281,857 | ||||||
Loading xslF345X06/ownership.xml…